SCOTT MERCER

Allopathic & Osteopathic Physicians|Family Medicine ENCINITAS, CA NPI 1295736031

General Payments — all program years on this page

$3,519.67

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 181
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $379.00 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $379.0013

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $152.292
GlaxoSmithKline, LLC. $84.834
Verity Pharmaceuticals Inc. $42.502
Acerta Pharma LLC $42.012
IDORSIA PHARMACEUTICALS US INC $20.091
Seqirus USA Inc $18.801
Grifols USA, LLC $18.481

By program year

Program yearAmountRecords
2018 $732.2146
2019 $550.7435
2020 $316.6215
2021 $579.4830
2022 $421.6619
2023 $539.9623
2024 $379.0013

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080608871 Verity Pharmaceuticals Inc. $20.36 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080608875 Verity Pharmaceuticals Inc. $22.14 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104218567 AstraZeneca Pharmaceuticals LP $21.79 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104677101 AstraZeneca Pharmaceuticals LP $20.22 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115927958 Amgen Inc. $27.29 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115927964 Amgen Inc. $125.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116241723 GlaxoSmithKline, LLC. $23.49 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116405307 GlaxoSmithKline, LLC. $16.18 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116461260 GlaxoSmithKline, LLC. $21.27 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116477672 GlaxoSmithKline, LLC. $23.89 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124733255 Grifols USA, LLC $18.48 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125628574 Seqirus USA Inc $18.80 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146754345 IDORSIA PHARMACEUTICALS US INC $20.09 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.